Does dulaglutide reduce heart attack risk?

Yes. Its own careful study showed it lowered heart risk, which is part of why that use is on its FDA approved label as Trulicity. That is a result for this one drug. It does not apply to every GLP-1 drug just because they act on the same receptor.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.